You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adrenergic Agents

Showing 1 - 25 of 5,946
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PTSD Trial in Berlin, Hamburg, Mannheim (Clonidine, Doxazosin, Placebo)

Recruiting
  • Posttraumatic Stress Disorder
  • Berlin, Germany
  • +3 more
Apr 29, 2022

Anesthesia Intubation Complication Trial in Zagazig (Nebulized Dexmedetomidine, Nebulized Lidocaine, Intravenous

Not yet recruiting
  • Anesthesia Intubation Complication
  • Nebulized Dexmedetomidine
  • +3 more
  • Zagazig, Al-Sharkia, Egypt
    Faculty of medicine, Zagazig University
Jul 4, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Outcome Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Outcome
  • (no location specified)
Nov 28, 2023

Mydriasis, Dilation Trial in Longwood, Athens (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle)

Completed
  • Mydriasis
  • Dilation
  • Phentolamine Ophthalmic Solution 0.75%
  • Phentolamine Ophthalmic Solution Vehicle
  • Longwood, Florida
  • +1 more
Jun 20, 2022

Outcome Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Outcome
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Emergence Agitation Trial in Shanghai (Esketamine, Sevoflurane)

Recruiting
  • Emergence Agitation
  • Shanghai, Shanghai, China
    Anesthesiology Department of Affiliated Eye and ENT Hospital, Fu
Dec 3, 2022

Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic, Ventricular Remodeling Trial in Aurora, Columbus (Ivabradine,

Active, not recruiting
  • Dilated Cardiomyopathies, Idiopathic
  • +3 more
  • Aurora, Colorado
  • +1 more
Oct 31, 2022

Cystic Fibrosis, CFTR Gene Dysfunction Trial (Beta Adrenergic Sweat Test)

Withdrawn
  • Cystic Fibrosis
  • CFTR Gene Dysfunction
  • Beta Adrenergic Sweat Test
  • (no location specified)
Jul 12, 2021

Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction Trial in New York (Beta blocker)

Recruiting
  • Heart Failure
  • +4 more
  • Beta blocker
  • New York, New York
    Weill Cornell Medicine
Jan 31, 2023

Septic Shock, Refractory Shock, Norepinephrine Adverse Reaction Trial in Bangkok (Terlipressin, Placebo)

Recruiting
  • Septic Shock
  • +2 more
  • Bangkok, Thailand
    Department of Medicine, Faculty of Medicine Siriraj Hospital, Ma
Sep 23, 2021

Urgency Urinary Incontinence Trial in United States (Beta3-Agonists, Adrenergic, OnabotulinumtoxinA 100 UNT [Botox])

Not yet recruiting
  • Urgency Urinary Incontinence
  • Beta3-Agonists, Adrenergic
  • OnabotulinumtoxinA 100 UNT [Botox]
  • Birmingham, Alabama
  • +4 more
Mar 28, 2023

REM Sleep Behavior Disorder, Pre-motor Parkinson Disease, Symptomatic Parkinson Disease Trial in Los Angeles (Carvedilol)

Recruiting
  • REM Sleep Behavior Disorder
  • +2 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Aug 23, 2022

Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)

Recruiting
  • Prader-Willi Syndrome
  • +20 more
  • Guanfacine Extended Release
  • Placebo
  • Brooklyn, New York
    Maimonides Medical Center
Dec 20, 2022

Nocturia Trial in Birmingham, Atlanta (Behavioral, tamsulosin (alpha-adrenergic antagonist medication), )

Completed
  • Nocturia
  • Behavioral
  • +2 more
  • Birmingham, Alabama
  • +1 more
Sep 9, 2021

Cardiac Arrhythmia, Supraventricular Arrhythmia Trial in Lodz (Comparison of atropine and isoprenaline)

Not yet recruiting
  • Cardiac Arrhythmia
  • Supraventricular Arrhythmia
  • Comparison of atropine and isoprenaline
  • Lodz, Poland
    Department of Electrocardiology Medical University of Lodz
Oct 9, 2023

Inhalation Anesthesia, Dexmedetomidine, Sevoflurane Trial in Montréal (Dexmedetomidine, Placebo)

Not yet recruiting
  • Inhalation Anesthesia
  • +3 more
  • Montréal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est de l'Ile de Montré
Nov 14, 2022

Glaucoma, OHT - Ocular Hypertension Trial in Rochester, Omaha, Columbus (Timolol 0.5% ophthalmic solution, Latanoprost 0.005%

Recruiting
  • Glaucoma
  • OHT - Ocular Hypertension
  • Timolol 0.5% ophthalmic solution
  • Latanoprost 0.005% Ophthalmic Solution
  • Rochester, Minnesota
  • +2 more
Jul 15, 2022

Bronchoscopy Trial in Taoyuan (Dexmedetomidine arm, Propofol arm)

Completed
Has Results
  • Bronchoscopy
  • Dexmedetomidine arm
  • Propofol arm
  • Taoyuan, Taiwan
    Department of Thoracic Medicine, Chang Gung Memorial Hospital
Aug 15, 2021

Mydriasis, Dilation Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle)

Completed
  • Mydriasis
  • Dilation
  • Phentolamine Ophthalmic Solution 0.75%
  • Phentolamine Ophthalmic Solution Vehicle
  • Newport Beach, California
  • +14 more
Jun 20, 2022